Related Experiment Video
Updated: Dec 5, 2025
07:30
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
7.2K
Psychotropic medication use patterns in home-based primary care: A scoping review
Nina Vadiei1, Carol L Howe2, Beth Zerr3
1Assistant Professor, University of Arizona College of Pharmacy, Tucson, Arizona; Assistant Professor, University of Arizona College of Medicine, Tucson, Arizona, vadiei@pharmacy.arizona.edu.
The Mental Health Clinician
|October 16, 2020
Summary
Limited studies show psychotropic medication patterns in home-based primary care (HBPC). More research is needed to understand prescribing trends and ensure patient safety for mental health conditions in HBPC settings.
Area of Science:
- Geriatrics
- Psychiatry
- Health Services Research
Background:
- Mental health conditions affect up to one-third of patients receiving home-based primary care (HBPC).
- These conditions are frequently underrecognized and undertreated within HBPC services.
- Psychotropic medication use in this population is not well-documented.
Purpose of the Study:
- To conduct a scoping review of current psychotropic medication use patterns among patients receiving HBPC.
- To identify gaps in the literature regarding psychotropic prescribing in HBPC.
Main Methods:
- A comprehensive search of multiple databases (Ovid/MEDLINE, Cochrane Library, Embase, Scopus, Web of Science, CINAHL, PsycInfo) was performed.
- Studies focusing on HBPC settings and psychotropic prescribing patterns were included.
- Exclusion criteria included studies solely on hospice, rehabilitation, long-term care, drug trials, opinion pieces, case studies, and reviews.
Main Results:
- Only 2 studies met the inclusion criteria out of 4542 initially identified articles.
- One study reported antidepressant (41.7%), antipsychotic (21.5%), and benzodiazepine/hypnotic (5-7%) use.
- The second study indicated antipsychotic (9%) and benzodiazepine (7%) use.
Conclusions:
- Published data on psychotropic prescribing patterns in HBPC are extremely limited.
- The complexity of treating co-occurring mental health and chronic conditions in HBPC necessitates further investigation.
- Additional research is crucial to inform interventions promoting patient safety in HBPC settings.
More Related Videos
Related Concept Videos
01:26Psychosis: Goals of Pharmacotherapy
350
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
350
01:28Drug Therapy
184
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
184
01:28Psychosis and Antipsychotic Drugs: Overview
665
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
665
01:23Antidepressant Drugs: MAOIs and Other Agents
643
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
643
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
491
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
491
01:21Antipsychotic Drugs: Typical and Atypical Agents
590
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
590